Aralez Pharma (ARLZ) Misses Q4 EPS by 12c; Announces Resubmission of YOSPRALA NDA

Go back to Aralez Pharma (ARLZ) Misses Q4 EPS by 12c; Announces Resubmission of YOSPRALA NDA

Form 8-K Aralez Pharmaceuticals For: Mar 15

March 15, 2016 7:31 AM EDT

 

 

UNITED STATES

... More

Form 8-K Aralez Pharmaceuticals For: Mar 14

March 14, 2016 4:11 PM EDT

 

 

UNITED STATES

SECURITIES AND EXCHANGE... More